Literature DB >> 12140916

Endocrine and metabolic issues in the management of the chronically critically ill patient.

Jeffrey I Mechanick1, Elise M Brett.   

Abstract

The metabolic syndrome of chronic critical illness (CCI) consists of multisystem organ dysfunction resulting from the initial acute injury and chronic immune-neuroendocrine axis activation, adult kwashiorkor-like malnutrition, and prolonged immobilization with suppression of the PTH-vitamin D axis and hyper-resorptive metabolic bone disease. CCI patients can also present unique challenges in the management of diabetes mellitus, thyroid and adrenal diseases, electrolyte abnormalities and hypogonadism.

Entities:  

Mesh:

Year:  2002        PMID: 12140916     DOI: 10.1016/s0749-0704(02)00005-2

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  4 in total

Review 1.  The association between critical illness and changes in bone turnover in adults: a systematic review.

Authors:  N Orford; C Cattigan; S L Brennan; M Kotowicz; J Pasco; D J Cooper
Journal:  Osteoporos Int       Date:  2014-05-07       Impact factor: 4.507

2.  Deciding in the dark: advance directives and continuation of treatment in chronic critical illness.

Authors:  Sharon L Camhi; Alice F Mercado; R Sean Morrison; Qingling Du; David M Platt; Gary I August; Judith E Nelson
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

Review 3.  Chronic critical illness: are we saving patients or creating victims?

Authors:  Sergio Henrique Loss; Diego Silva Leite Nunes; Oellen Stuani Franzosi; Gabriela Soranço Salazar; Cassiano Teixeira; Silvia Regina Rios Vieira
Journal:  Rev Bras Ter Intensiva       Date:  2017 Jan-Mar

Review 4.  Oral Nutrition during and after Critical Illness: SPICES for Quality of Care!

Authors:  Marjorie Fadeur; Jean-Charles Preiser; Anne-Marie Verbrugge; Benoit Misset; Anne-Françoise Rousseau
Journal:  Nutrients       Date:  2020-11-14       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.